Kimia Biosciences share news, announcements and annual reports
BSE: 530313Pharmaceuticals & BiotechnologySmall Cap
KIMIA BIOSCIENCES LIMITED · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1995
Last close ₹29.16down ₹1.29 (4.24%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹30.45.
30 Oct: open ₹31.49, high ₹31.49, low ₹29.01
52-week range of traded prices to 30 Oct 2026
₹23.20Low, 30 Mar 2026₹43.28High, 16 Feb 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹138 Cr2,580th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 19.20
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 7.79
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 51.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.95
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 237
Kimia Biosciences routine notices
189 filed, newest first. Page 4 of 4.
Sep 2020
Aug 2020
21 Aug · Routine
7 Aug · Routine
Jul 2020
Jun 2020
Apr 2020
Mar 2020
31 Mar · Routine
Feb 2020
15 Feb · Routine
Jan 2020
Dec 2019
Oct 2019
25 Oct · Routine
Sep 2019
5 Sep · Routine
Aug 2019
13 Aug · Routine
Jul 2019
May 2019
24 May · Routine
Apr 2019
Feb 2019
12 Feb · Routine
Nov 2018
Oct 2018
Sep 2018
4 Sep · Routine
Aug 2018
May 2018
15 May · Routine
Dec 2017
8 Dec · Routine
Jan 2017
Aug 2016
May 2016
21 May · Routine
Meeting of board of directors is schedule to be held on May 30, 2016, inter alia, to consider and approve Annual Audited Standalone and Consolidated ....